Articles Vol. 66 No. CĐ16-HNKH Bệnh viện Nhi Đồng 2 02/10/2025

27. OUTCOMES OF ESOPHAGEAL DILATION IN PATIENTS WITH CONGENITAL ESOPHAGEAL ATRESIA AT CHILDREN’S HOSPITAL 2: CASE SERIES

Duong Chau Giang1, Vu Truong Nhan1, Bui Thi Huong Ging1, Pham Ngoc Mai Anh1, Nguyen Thi Thu Thuy1
1 Bệnh viện Nhi Đồng 2
Corresponding author: dcgiang194@gmail.com
DOI: 10.52163/yhc.v66iCD16.3339
29 Views
18 Downloads
Abstract

Objective: To describe the characteristics and outcomes of esophageal dilation in children with anastomotic strictures following surgery for congenital esophageal atresia at Children’s Hospital 2 from January 2022 to December 2023, with a follow-up period of 6 months.

Subjects and methods: A retrospective descriptive case series study. The study subjects were children with esophageal atresia who underwent surgery and were followed up at Children’s Hospital 2, admitted between January 1, 2022, and December 31, 2023.

Results: There were 46 patients diagnosed with esophageal atresia, with type C being the most common, accounting for 39 cases (84.8%). Associated congenital anomalies were present in 89% of the patients. Esophageal dilation was performed in 12 (26%) cases due to anastomotic strictures. The median age at the time of dilation was 8 months (1.5–52.5 months). The median number of dilation procedures was 2 (1-3.5), with a minimum of 1 and a maximum of 6 sessions. 7 cases required multiple dilations, with a median interval between dilations of 3.5 months (1–11 months). Dilation methods included Maloney bougies (46.4%), balloon dilation (39.3%), a combination of both methods (25%), and Tucker dilators (8%). The success rate after the first dilation was 42%, after 2–4 sessions was 25%, and after 6 sessions was 8%; 25% of cases were unsuccessful. Other complications included pneumothorax/pleural effusion (39.1%), recurrent pneumonia (19.6%), prolonged wheezing (17.4%), and recurrent tracheoesophageal fistula (6.5%). No fatal complications were reported.

Conclusion: Congenital esophageal atresia is often associated with other congenital anomalies. Esophageal dilation using balloons or Maloney bougies are effective and safe methods; however, the rate of restenosis remains high. Attention should be given to managing coexisting conditions and other complications. Additionally, alternative methods, such as esophageal stenting, may be considered.

References
[1]
Diễm Lê Nguyễn Ngọc, Định Trương Quang (2016). Đánh giá kết quả nong thực quản bằng bộ nong maloney và tucker trên trẻ hẹp miệng nối sau mổ teo thực quản bẩm sinh. Tạp chí Y học TP. Hồ Chí Minh, 20(5): p. 174-179. Google Scholar
[2]
Khôi Nguyễn Minh, Tuân Tô Mạnh (2023). Kết quả phẫu thuật nội soi điều trị teo thực quản bẩm sinh tại bệnh viện nhi trung ương. Tạp chí Y học Việt Nam, 529(2). Google Scholar
[3]
Tâm Bùi Thị Thùy, Tuấn Nguyễn Anh. (2014). Đặc điểm các trường hợp teo thực quản bẩm sinh tại Bệnh viện Nhi Đồng 2 từ 2007 - 2012. Tạp chí Y học TP. Hồ Chí Minh, 18(1): p. 381. Google Scholar
[4]
Uyên Nguyễn Thị Bích, Quỳnh Huỳnh Kim. (2022). Kết quả điều trị hẹp thực quản bằng nong thực quản qua nội soi tại bệnh viện nhi đồng 1. Tạp chí Y học TP. Hồ Chí Minh,26(1): p. 106. Google Scholar
[5]
Besendorfer, M., et al., (2021). Association of clinical factors with postoperative complications of esophageal atresia. Pediatr Neonatol, 62(1): p. 55-63. Google Scholar
[6]
Krishnan, U., et al., (2016). ESPGHAN-NASPGHAN Guidelines for the Evaluation and Treatment of Gastrointestinal and Nutritional Complications in Children With Esophageal Atresia-Tracheoesophageal Fistula. J Pediatr Gastroenterol Nutr, 63(5): p. 550-570. Google Scholar
[7]
Tambucci, R., et al., (2017).Anastomotic Strictures after Esophageal Atresia Repair: Incidence, Investigations, and Management, Including Treatment of Refractory and Recurrent Strictures. Front Pediatr, 5: p. 120. Google Scholar
[8]
Cassina, M., et al., (2016). Prevalence, characteristics, and survival of children with esophageal atresia: A 32-year population-based study including 1,417,724 consecutive newborns. Birth Defects Res A Clin Mol Teratol, 106(7): p. 542-8. Google Scholar